摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-(3-acetylphenyl)-3-amino-N-methylpyrazine-2-carboxamide

中文名称
——
中文别名
——
英文名称
6-(3-acetylphenyl)-3-amino-N-methylpyrazine-2-carboxamide
英文别名
——
6-(3-acetylphenyl)-3-amino-N-methylpyrazine-2-carboxamide化学式
CAS
——
化学式
C14H14N4O2
mdl
——
分子量
270.29
InChiKey
RKZYYAHGMJYPHA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    98
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • Protein kinase modulators and methods of use
    申请人:Buhr A. Chris
    公开号:US20060211709A1
    公开(公告)日:2006-09-21
    Substituted aryl 1,4-pyrazine derivatives and their use in treating anxiety disorders, depression and stress related disorders are disclosed.
    本发明揭示了替代芳基1,4-吡嗪生物及其在治疗焦虑症、抑郁症和与压力相关的疾病中的应用。
  • PROTEIN KINASE MODULATORS AND METHODS OF USE
    申请人:Exelixis, Inc.
    公开号:EP1501514A2
    公开(公告)日:2005-02-02
  • EP1501514A4
    申请人:——
    公开号:EP1501514A4
    公开(公告)日:2009-08-26
  • US7704995B2
    申请人:——
    公开号:US7704995B2
    公开(公告)日:2010-04-27
  • [EN] PROTEIN KINASE MODULATORS AND METHODS OF USE<br/>[FR] MODULATEURS DE PROTEINE KINASE ET PROCEDES D'UTILISATION
    申请人:EXELIXIS INC
    公开号:WO2003093297A2
    公开(公告)日:2003-11-13
    This invention relates to compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion, and to pharmaceutical compositions containing such compounds. Even more specifically, the invention relates to compounds that inhibit, regulate and/or modulate kinases, particularly Checkpoint Kinases, even more particularly Checkpoint Kinase 1, or Chk1. Methods of therapeutically or prophylactically using the compounds and compositions to treat kinase-dependent diseases and conditions are also an aspect of the invention, and include methods of treating cancer, as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation, by administering effective amounts of such compounds.
查看更多